Filing Details

Accession Number:
0001728117-23-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-22 17:17:06
Reporting Period:
2023-03-20
Accepted Time:
2023-03-22 17:17:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728117 Gossamer Bio Inc. GOSS Pharmaceutical Preparations (2834) 475461709
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740847 Bryan Giraudo 3013 Science Park Road
San Diego CA 92121
Coo/Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-20 50,000 $0.97 70,990 No 4 P Indirect By family trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By family trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2023-03-20 211,500 $0.00 211,500 $1.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
211,500 2033-03-19 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,167 Direct
Footnotes
  1. 25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.